What is the management of acute subdural hematoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The management of acute subdural hematoma requires urgent neurosurgical evaluation and often surgical intervention, with primary decompressive craniectomy being a viable option, as evidenced by a recent study published in The Lancet Neurology 1. The goal of treatment is to prevent further brain injury and improve outcomes, with a focus on reducing morbidity, mortality, and enhancing quality of life.

  • Key considerations in the management of acute subdural hematoma include:
    • Urgent neurosurgical evaluation to determine the need for surgical intervention
    • Surgical evacuation via craniotomy or primary decompressive craniectomy for significant hematomas or neurological deficits
    • Medical management to prevent secondary brain injury, including intracranial pressure (ICP) control, head elevation, and maintenance of optimal blood pressure and oxygenation
    • Seizure prophylaxis with medications such as levetiracetam
    • Temperature control, normoglycemia, and adequate oxygenation
  • A study published in The Lancet Neurology in 2022 found significant variation in the management of acute subdural hematoma between centers, with a median odds ratio (MOR) of 1.84 for acute surgery and 2.68 for primary decompressive craniectomy 1.
  • The management approach should be individualized based on the patient's specific condition, with a focus on minimizing morbidity and mortality, and improving quality of life, as supported by the most recent and highest quality evidence 1.

From the Research

Management of Acute Subdural Hematoma

The management of acute subdural hematoma (ASDH) involves a combination of surgical and non-surgical approaches. The choice of treatment strategy depends on various factors, including the severity of the injury, the patient's age, and the presence of other medical conditions.

Surgical Management

  • Decompressive craniectomy and craniotomy are two common surgical procedures used to treat ASDH 2.
  • Decompressive craniectomy is often performed in patients with high-energy trauma and a Glasgow Coma Scale (GCS) score of 8 or less 2.
  • Craniotomy is also used to evacuate the hematoma and relieve pressure on the brain 3.
  • The choice of surgical procedure depends on the individual patient's condition and the surgeon's preference 2.

Non-Surgical Management

  • Non-operative management may be considered for patients with a small hematoma and minimal symptoms 4.
  • Patients with a GCS score of 3 or less are often considered for surgical intervention, while those with a GCS score of 7 or more may be managed non-operatively 5.
  • The use of long-lasting paralytic agents should be avoided to allow for accurate assessment of the patient's neurological status 4.

Predictive Factors of Outcome

  • The GCS score at admission is a significant predictor of outcome in patients with ASDH 6, 3, 4, 5.
  • Age, presence of antithrombotic therapy, and type of surgical intervention are also important factors that influence outcome 3, 5.
  • Male gender and anisocoric pupils are associated with a poorer outcome in patients with ASDH 3.

Complications and Mortality

  • The mortality rate for patients with ASDH is significant, ranging from 26% to 55% in different studies 2, 3, 5.
  • Complications such as brain swelling, herniation, and seizures can occur in patients with ASDH, and prompt recognition and treatment are essential to improve outcomes 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.